| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $145.9M | $103.9M | $79.6M |
| YoY Revenue Growth % | +40.5% | +30.5% | — |
| Gross Profit | $75.3M | $59.5M | — |
| Gross Margin % | 51.6% | 57.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$48.5M | -$82.3M | -$90.1M |
| Operating Margin % | -33.2% | -79.2% | -80.0% |
| Net Income (GAAP) | -$33.1M | -$54.0M | -$108.0M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $18.7M | -$30.9M | -$9.8M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $18.7M | -$30.9M | -$9.8M |
| FCF Margin % | 12.8% | -29.7% | -12.3% |
| Return on Invested Capital (ROIC %) | -38.7% | -45.0% | — |
| Cash & Short-Term Equivalents | $49.1M | $37.0M | — |
| Total Debt (Short + Long Term) | $28.6M | $0 | — |
| Total Stockholders' Equity | $119.4M | $117.7M | — |